Last updated: November 8, 2023
Sponsor: University of Rochester
Overall Status: Completed
Phase
N/A
Condition
Mild Cognitive Impairment
Dementia
Mental Disability
Treatment
MAAT-G
Clinical Study ID
NCT04230941
UCCS19102
1K76AG064394-01
Ages > 65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Patient Inclusion Criteria:
- Have a diagnosis of invasive breast cancer
- Planned to receive systemic therapy for breast cancer or actively receiving systemictherapy for breast cancer with two additional cycles remaining.
- Be age 65 or older
- Able to provide informed consent
- Able to read and understand English (or possess a designated health care proxy thatcan do the same that was designated prior to the patient losing decision-makingcapabilities)
Exclusion
Patient Exclusion Criteria:
- Have surgery planned within 3 months of consent
- Patients who do not have decision-making capacity (decisionally or cognitivelyimpaired) AND do NOT have a previously designated health care proxy (established priorto their cognitive impairment) available to sign consent
- Patients with breast cancer receiving endocrine therapy as their only systemic therapywill not be eligible. Eligible Caregiver Inclusion Criteria:
- Selected by the patient when asked if there is a "family member, partner, friend orcaregiver [age 21 or older] with whom you discuss or who can be helpful in health-relatedmatters;" patients who cannot identify such a person ("caregiver") will remain eligible forthe study. Eligible Caregiver Exclusion Criteria:
- Caregivers unable to understand the consent form due to cognitive, health or sensoryimpairment will be excluded
Study Design
Total Participants: 4
Treatment Group(s): 1
Primary Treatment: MAAT-G
Phase:
Study Start date:
June 12, 2020
Estimated Completion Date:
February 01, 2022
Study Description
Connect with a study center
University of Rochester Medical Center
Rochester, New York 14642
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.